PASATRU™ (garetosmab-grts)
| Full Name | PASATRU™ (garetosmab-grts) |
| Drug | PASATRU™ |
| Manufacturer | Regeneron Pharmaceuticals |
| Route of Administration | Intravenous |
| Site of Care | Home or Healthcare Facility |
| Approved Indication | To reduce formation of new heterotopic ossification (HO) lesions and clinician-assessed flare-ups in adults with fibrodysplasia ossificans progressiva (FOP) |
| Disease | Fibrodysplasia Ossificans Progressiva (FOP) |
| Therapeutic Area | Rheumatology, Genetics |
| Enrollment Form Link | www.pasatruhcp.com |
| Phone Number | 847-464-8049 |
| Fax Number | 847-892-1181 |
| Product Website | www.pasatruhcp.com |